← Leaderboards
Alan G. Barbour
University Of California Irvine
$21,826,711
Attributed
$24,263,793
Total exposure
14
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $14.7M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$113,032,138 · 15
By mechanism
U54$101,604,362 · 5
R01$5,366,431 · 3
R37$3,532,317 · 1
R21$1,704,136 · 4
R56$670,392 · 1
R03$154,500 · 1
Top collaborators
- Anthony Douglas Long8 shared
- Linda K Bockenstedt1 shared
- Peter James Krause1 shared
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionLyme DiseaseBasePathogenBorreliaImmune ResponseResourcesCommunicable DiseasesTicksAnimalsBorrelia BurgdorferiEvolutionPeromyscusGeneticBloodAntibodiesImmunityEmerging Communicable DiseasesVariantBiologyMammalsGenesInfectious Diseases ResearchBiodefense
Grant awards (60)
Basic immunological toolbox for genus Peromsycus, infection tolerant reservoirs of zoonotic agents$431,750
R21 · FY2025 · AI · contact PI
Genetic architecture of host response to tickborne disease in Peromyscus leucopus$599,781
R01 · FY2024 · AI
Genetic architecture of host response to tickborne disease in Peromyscus leucopus$637,988
R01 · FY2023 · AI
Genetic architecture of host response to tickborne disease in Peromyscus leucopus$667,464
R01 · FY2022 · AI
Genetic architecture of host response to tickborne disease in Peromyscus leucopus$235,007
R01 · FY2022 · AI
Genetic architecture of host response to tickborne disease in Peromyscus leucopus$691,155
R01 · FY2021 · AI
Genetic architecture of host response to tickborne disease in Peromyscus leucopus$724,038
R01 · FY2020 · AI
Development of Peromyscus leucopus as a model organism for research on Lyme disease and other emerging zoonoses$193,125
R21 · FY2019 · AI · contact PI
Evolution and population biology of the relapsing fever agent Borrelia hermsii in California$77,250
R03 · FY2019 · AI · contact PI
Development of Peromyscus leucopus as a model organism for research on Lyme disease and other emerging zoonoses$231,750
R21 · FY2018 · AI · contact PI
Evolution and population biology of the relapsing fever agent Borrelia hermsii in California$77,250
R03 · FY2018 · AI · contact PI
A heterogeneous stock paradigm of dissecting complex traits in Peromyscus leucopus, a major natural host of Lyme disease and other emerging infections$154,500
R21 · FY2017 · AI
A heterogeneous stock paradigm of dissecting complex traits in Peromyscus leucopus, a major natural host of Lyme disease and other emerging infections$270,375
R21 · FY2016 · AI
Borrelia Miyamotoi Infection in Mice and Humans$670,392
R56 · FY2015 · AI
Pacific Southwest RCE for Biodefense & Emerging Infectious Diseases Research$8,653,168
U54 · FY2013 · AI · contact PI
Administrative Core$1,603,094
U54 · FY2013 · AI · contact PI
Identification of signature gases for the diagnosis of infectious diseases$431,288
U54 · FY2013 · AI · contact PI
Informative immunodiagnostics for Lyme disease$192,448
R21 · FY2013 · AI · contact PI
Infection and Immunity in Reservoir Hosts$131,294
U54 · FY2013 · AI · contact PI
Pacific Southwest RCE for Biodefense & Emerging Infectious Diseases Research$9,206,084
U54 · FY2012 · AI · contact PI
Administrative Core$1,381,767
U54 · FY2012 · AI · contact PI
Identification of signature gases for the diagnosis of infectious diseases$303,864
U54 · FY2012 · AI · contact PI
Informative immunodiagnostics for Lyme disease$230,188
R21 · FY2012 · AI · contact PI
Infection and Immunity in Reservoir Hosts$224,275
U54 · FY2012 · AI · contact PI
Pacific Southwest RCE for Biodefense & Emerging Infectious Diseases Research$11,075
U54 · FY2012 · AI · contact PI
Pacific Southwest RCE for Biodefense & Emerging Infectious Diseases Research$8,985,358
U54 · FY2011 · AI · contact PI
Administrative Core$779,728
U54 · FY2011 · AI · contact PI
Infection and Immunity in Reservoir Hosts$170,569
U54 · FY2011 · AI · contact PI
Pacific Southwest RCE for Biodefense & Emerging Infectious Diseases Research$8,627,554
U54 · FY2010 · AI · contact PI
Administrative Core$562,705
U54 · FY2010 · AI · contact PI
MOLECULAR BASIS OF BORRELIA PATHOGENESIS$344,719
R37 · FY2010 · AI · contact PI
Infection and Immunity in Reservoir Hosts$159,440
U54 · FY2010 · AI · contact PI
Pacific Southwest RCE for Biodefense & Emerging Infectious Diseases Research$146,092
U54 · FY2010 · AI · contact PI
Pacific Southwest RCE for Biodefense & Emerging Infectious Diseases Research$9,625,099
U54 · FY2009 · AI · contact PI
Pacific Southwest RCE for Biodefense & Emerging Infectious Diseases Research$3,853,630
U54 · FY2009 · AI · contact PI
Administrative Core$711,951
U54 · FY2009 · AI · contact PI
MOLECULAR BASIS OF BORRELIA PATHOGENESIS$349,653
R37 · FY2009 · AI · contact PI
Reservoir Vaccines$162,208
U54 · FY2009 · AI · contact PI
Pacific-Southwest Ctr for Biodefense & Emerg Infect Dis*$10,078,421
U54 · FY2008 · AI · contact PI
Administrative Core$1,621,895
U54 · FY2008 · AI · contact PI
MOLECULAR BASIS OF BORRELIA PATHOGENESIS$350,963
R37 · FY2008 · AI · contact PI
Pacific-Southwest Ctr for Biodefense & Emerg Infect Dis*$9,805,034
U54 · FY2007 · AI · contact PI
Administrative Core$1,573,950
U54 · FY2007 · AI · contact PI
MOLECULAR BASIS OF BORRELIA PATHOGENESIS$358,965
R37 · FY2007 · AI · contact PI
Pacific-Southwest Ctr for Biodefense & Emerg Infect Dis*$9,796,830
U54 · FY2006 · AI · contact PI
Administrative Core$1,334,149
U54 · FY2006 · AI · contact PI
MOLECULAR BASIS OF BORRELIA PATHOGENESIS$370,808
R37 · FY2006 · AI · contact PI
Pacific-Southwest Ctr for Biodefense &Emerg Infect Dis*$9,980,000
U54 · FY2005 · AI
Administrative Core$1,683,840
U54 · FY2005 · AI
MOLECULAR BASIS OF BORRELIA PATHOGENESIS$351,183
R37 · FY2005 · AI
MOLECULAR BASIS OF BORRELIA PATHOGENESIS$351,906
R37 · FY2004 · AI
BIOLOGY AND CONTROL OF LYME DISEASE BORRELIA$291,879
R01 · FY2004 · AI
MOLECULAR BASIS OF BORRELIA PATHOGENESIS$352,608
R37 · FY2003 · AI
BIOLOGY AND CONTROL OF LYME DISEASE BORRELIA$291,879
R01 · FY2003 · AI
MOLECULAR BASIS OF BORRELIA PATHOGENESIS$353,289
R37 · FY2002 · AI
BIOLOGY AND CONTROL OF LYME DISEASE BORRELIA$291,879
R01 · FY2002 · AI
MOLECULAR BASIS OF BORRELIA PATHOGENESIS$348,223
R37 · FY2001 · AI
BIOLOGY AND CONTROL OF LYME DISEASE BORRELIA$291,879
R01 · FY2001 · AI
MOLECULAR BASIS OF BORRELIA PATHOGENESIS$339,003
R01 · FY2000 · AI
BIOLOGY AND CONTROL OF LYME DISEASE BORRELIA$304,479
R01 · FY2000 · AI